CAS: 13242-44-9; 2-(N,N-Dimethylamino)Ethylthiol Hydrochloride

该化合物是一种化学化合物,其特征为硫醇功能组,具有不同特性,如反应和形成硫化物结层的能力.该化合物是一种盐酸盐,表明它通常以稳定,水溶性的形式出现.它具有二甲基氨基组,有助于其基本性和核循环行为的潜力.由于该二醇组的存在,它是一种减少剂,可以参与各种化学反应,包括氧化性减低过程.从物理特性来看,它一般没有色,可与淡黄色液体或固体有关,具有一种特质.该化合物通常用于有机合成,特别是在其他含硫化合物的化合物的制造过程中,并且可能用于制药和生物化学.与许多硫化物一样,它应该谨慎处理,因为其潜在的毒性和再活性.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

(2-chloroethyl)dimethylamine hydr°Chloride N-Benzyl-dithi°Carbaminsaeure-(2-dimethylamino-ethylester) 3-(2-Dimethylamino-aethylmercapto)-rifamycin SV b,f]thiepin-10-ylsulfanyl)-ethyl]-dimethyl-amine[2-(8-chloro-10,11-dihydro-dibenzo[b,f]thiepin-10-ylsulfanyl)-ethyl]-dimethyl-amine Dimethyl-[2-(7-methyl-3-phenyl-quinolin-2-ylsulfanyl)-ethyl]-amine

合成工艺路线路线简述

    二甲氨基氯乙烷盐酸置于sodium Thiosulfate,盐酸体系中,用 水 用作溶剂,化学反应 12.0H,反应生成2-甲胺乙硫醇盐酸盐
    参考文献:Facile Conversion Of Cysteine And Alkyl Cysteines To Dehydroalanine On Protein Surfaces: Versatile And Switchable Access To Functionalized Proteins
    标题:Facile Conversion Of Cysteine And Alkyl Cysteines To Dehydroalanine On Protein Surfaces: Versatile And Switchable Access To Functionalized Proteins
    摘要:An Efficient And Robust Oxidative Elimination Of Cysteine To Dehydroalanine Has Been Discovered. The Reaction Is Induced By O-Mesitylenesulfonylhydroxylamine (Msh) And Is Compatible With Methionine. The Key Elimination Has Been Executed On Protein Surfaces And Allows Ready Access To Different Post-Translationally Modified Proteins Through Conjugate Addition Of Sulfur Nucleophiles To Dehydroalanine. Treatment Of The Resulting Thioether With Msh Results In Regeneration Of Dehydroalanine,Allowing A "Functional Switch" By Subsequent Addition Of A Different Thiol.
    Doi:10.1021/ja800800P

    海关参考信息

    专利信息


    专利号:US-5304647-A
    优先权日:1988-02-09
    标题:Method of preparation of halogenated diazines
    发明人:STREKOWSKI LUCJAN; MOKROSZ MARIA; HARDEN DONALD B
    权利人:UNIV GEORGIA STATE
    摘要:A method of preparation of substituted halogenodiazines which are useful as intermediates in the synthesis of novel unfused heterobicyclic compounds, and the products thereof. The reaction consists of the addition of an organolithium reagent with subsequent dehydrogenation of the addition product. The reaction takes place in one reaction vessel, without isolation of the substituted halogenodihydrodiazine intermediate. The reactions proceed at moderate temperature and in a short amount of time, which decreases the probability of side reactions and increases yield. Furthermore, the workup step is conducted under two-phase conditions to prevent hydrolysis of the substituted halogenodiazine to a substituted hydroxydiazine. The method is easy, efficient and results in a high yield of product. The substituted halogenodiazines are used as intermediates in the synthesis of unfused heterobicyclic compounds containing an aromatic moiety, diazine, and another aromatic moiety, such as thiophene, benzene, or naphthalene, which have biological activity.

    专利号:US-2024400558-A1
    优先权日:2021-09-09
    标题 :Processes and intermediates for synthesis of adagrasib
    发明人:SCATTOLIN THOMAS; CHEN CHENG; GHARBAOUI TAWFIK; GAN YONGHONG; ACHMATOWICZ MICHAL; SNEAD DAVID
    权利人:MIRATI THERAPEUTICS INC
    摘要:The present invention relates to improved synthetic routes of synthesizing adagrasib. The invention also provides intermediates used in the provided synthetic routes.

    专利号:US-5214130-A
    优先权日:1990-02-27
    标题 :Synthesis of novel immunosuppressive cyclosporin analogs with modified amino acids at position-8
    发明人:PATCHETT ARTHUR A; TAUB DAVID; GOEGELMAN ROBERT T
    权利人:MERCK & CO INC
    摘要:New immunosuppressive cyclosporin analogs are disclosed consisting of [dehydro-Ala]8 cyclosporins and derived therefrom cyclosporins having a sulfur containing amino acid at position-8.

    专利号:US-4963676-A
    优先权日:1988-02-09
    标题 :Di-substituted phthalazines
    发明人:STREKOWSKI LUCJAN; MOKROSZ MARIA; HARDEN DONALD B
    权利人:UNIV GEORGIA STATE
    摘要:A method of preparation of substituted halogenodiazines which are useful as intermediates in the synthesis of novel unfused heterobicyclic compounds, and the products thereof. The reaction consists of the addition of an organolithium reagent with subsequent dehydrogenation of the addition product. The reaction takes place in one reaction vessel, without isolation of the substituted halogenodihydrodiazine intermediate. The reactions proceed at moderate temperature and in a short amount of time, which decreases the probability of side reactions and increases yield. Furthermore, the workup step is conducted under two-phase conditions to prevent hydrolysis of the substituted halogenodiazine to a substituted hydroxydiazine. The method is easy, efficient and results in a high yield of product. The substituted halogenodiazines are used as intermediates in the synthesis of novel unfused heterobicyclic compounds containing an aromatic moiety, diazine, and another aromatic moiety, such as thiophene, benzene, or naphthalene, which have biological activity.

    专利号:US-2018208555-A1
    优先权日:2013-11-18
    标题 :Method of synthesis of an ionizable cationic lipid

    专利号:US-2023250056-A1
    优先权日:2020-06-24
    标 题 :Process for synthesizing lipids
    发明人:BEUTNER GREGORY LOUIS; LORA GONZALEZ FEDERICO; CHO PATRICIA Y; SMITH MICHAEL J
    权利人:BRISTOL MYERS SQUIBB CO
    摘要:The present application provides processes for synthesizing lipids of Formula I useful in the synthesis of fat-soluble compounds for targeting and enhancing activity of therapeutic molecules, including siRNA.
    重庆卡兰医药有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.conier.com
    企业联系电话:023-62922305,18523575427👤
    📞重庆卡兰医药有限公司 ⚠️参考联系方式
    联系人:彭亮
    电话:023-62922305,18523575427
    手机:18523575427
    传真:023-62922305
    邮箱:2254263770@qq.com
    通信地址: 重庆市南岸区南坪亚太商谷5栋11楼
    邮编: 400060
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:重庆市南岸区南坪亚太商谷5栋11楼
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Yakugaku Zasshi. Journal of Pharmacy., 93(25), 1973 []
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知